Literature DB >> 11823475

Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase.

Eeva-Marja Rainio1, Jouko Sandholm, Päivi J Koskinen.   

Abstract

Pim-1 is an oncogenic serine/threonine kinase implicated in cytokine-induced signal transduction and in development of lymphoid malignancies. However, its precise function as well as physiological substrates have remained unknown. In this study we demonstrate that Pim-1 can physically interact with the NFATc1 transcription factor and phosphorylate it in vitro on several serine residues. In contrast to previously recognized NFATc kinases, wild-type Pim-1 enhances NFATc-dependent transactivation and IL-2 production in Jurkat T cells, while kinase-deficient Pim-1 mutants inhibit them in a dominant negative fashion. Our results reveal a novel, phosphorylation-dependent regulatory mechanism targeting NFATc1 through which Pim-1 acts as a downstream effector of Ras to facilitate IL-2-dependent proliferation and/or survival of lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823475     DOI: 10.4049/jimmunol.168.4.1524

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation.

Authors:  Yoo Seob Shin; Katsuyuki Takeda; Yoshiki Shiraishi; Yi Jia; Meiqin Wang; Leila Jackson; A Dale Wright; Laura Carter; John Robinson; Erik Hicken; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2011-11-10       Impact factor: 6.914

3.  Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor.

Authors:  Katriina Peltola; Maija Hollmen; Sanna-Mari Maula; Eeva Rainio; Raija Ristamäki; Marjaana Luukkaa; Jouko Sandholm; Maria Sundvall; Klaus Elenius; Päivi J Koskinen; Reidar Grenman; Sirpa Jalkanen
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

Authors:  Christian H Gabriel; Fridolin Gross; Martin Karl; Heike Stephanowitz; Anna Floriane Hennig; Melanie Weber; Stefanie Gryzik; Ivo Bachmann; Katharina Hecklau; Jürgen Wienands; Johannes Schuchhardt; Hanspeter Herzel; Andreas Radbruch; Eberhard Krause; Ria Baumgrass
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

Review 5.  The role of Pim kinase in immunomodulation.

Authors:  Zhaoyun Liu; Mei Han; Kai Ding; Rong Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

6.  Overexpression of Pim-1 during progression of prostatic adenocarcinoma.

Authors:  T L Cibull; T D Jones; L Li; J N Eble; L Ann Baldridge; S R Malott; Y Luo; L Cheng
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 7.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

8.  Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation.

Authors:  Teija L T Aho; Riikka J Lund; Emmi K Ylikoski; Sampsa Matikainen; Riitta Lahesmaa; Päivi J Koskinen
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

9.  PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.

Authors:  Zhiyuan Li; Fang Lin; Changhua Zhuo; Guoping Deng; Zuojia Chen; Shuying Yin; Zhimei Gao; Miranda Piccioni; Andy Tsun; Sanjun Cai; Song Guo Zheng; Yu Zhang; Bin Li
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

10.  Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Authors:  Niina M Santio; Riitta L Vahakoski; Eeva-Marja Rainio; Jouko A Sandholm; Sanna S Virtanen; Michelle Prudhomme; Fabrice Anizon; Pascale Moreau; Päivi J Koskinen
Journal:  Mol Cancer       Date:  2010-10-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.